Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 212 participants.

Also called NCT07243080

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 212 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07243080
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07243080. Randomized; single masking; primary purpose prevention. Start 2025-10-10 (actual); primary completion 2025-11-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention
Condition
Deep Venous Thromboses
Condition
Laparotomy Patients
Intervention (Drug)
rivaroxaban (10mg)
Intervention (Drug)
Enoxaparin 40 mg SC
Lead sponsor
Mayo Hospital Lahore (class: other)
Collaborator
King Edward Medical University (class: other)

Record details

Record id
cardio:ct-nct07243080
Content hash
79bd315e6ffa7682341443b35beb75c7981b407cb6d082f54dcbaa2b8d6ff545